CapsulesClinical Overview
Calcium Dobesilate Monohydrate Capsules (500mg) is an oral synthetic angioprotective and microvascular stabilizer on the PMBI Formulary. It improves microvascular resistance, inhibits capillary hyperpermeability, decreases blood hyperviscosity and platelet hyperaggregability, and improves lymphatic drainage. Indicated for diabetic retinopathy, chronic venous insufficiency, and acute hemorrhoidal attacks.
Active Pharmaceutical Ingredients
Verified Clinical References
Usage Guidelines
Take orally 500 mg once or twice daily with or after meals with a glass of water. Swallow whole.
General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.
Possible Side Effects
Common: Nausea, diarrhea, dyspepsia, mild fever, headache. Rare/Severe: Agranulocytosis / severe neutropenia (discontinue if fever occurs).
*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.
Precautions & Warnings
Discontinue immediately if unexplained fever, sore throat, or symptoms of infection occur (evaluate complete blood counts for agranulocytosis).
Schedule H (Prescription Required)
This medication is scheduled under statutory drug regulatory frameworks (CDSCO / Drugs & Cosmetics Rules). Dispensing requires a valid medical prescription from a registered medical practitioner. Self-medication or unsupervised dosage adjustment carries significant clinical risks.
Medical Disclaimer: Statutory Nutritional & Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice or clinical dietetic guidance. Dietary supplements, micronutrients, parenteral electrolytes, and specialized clinical nutrition should be used under the supervision of a registered medical practitioner or clinical nutritionist.
Calcium 500mg and Vitamin D3 250IU Tablets
Cholecalciferol (Vitamin D3 Drops 400 IU/ml, 800 IU/ml) is a physiological pediatric liquid formulation on the WHO Model List of Essential Medicines. Promotes normal bone growth and dentition in infants and children. Indicated for prevention of nutritional rickets and maintenance of healthy skeletal development in breastfed infants.
Calcium Carbonate 500mg, Calcitriol 0.25mcg and Zinc 7.5mg Capsules
Calcitriol Capsules (0.25mcg; alone or in bone complexes with Calcium, Vitamin K2-7, Zinc) is the biologically active hormonal form of vitamin D3 (1,25-dihydroxycholecalciferol) on the WHO Model List of Essential Medicines. Unlike cholecalciferol, it requires no metabolic activation by the liver or kidneys, directly activating intestinal calcium absorption and bone remodeling. Indicated for management of hypocalcemia and renal osteodystrophy in patients with chronic kidney disease, hypoparathyroidism, pseudohypoparathyroidism, and severe osteoporosis.
Calcium 500mg and Calcitriol 0.25mcg Tablets
Calcitriol Capsules (0.25mcg; alone or in bone complexes with Calcium, Vitamin K2-7, Zinc) is the biologically active hormonal form of vitamin D3 (1,25-dihydroxycholecalciferol) on the WHO Model List of Essential Medicines. Unlike cholecalciferol, it requires no metabolic activation by the liver or kidneys, directly activating intestinal calcium absorption and bone remodeling. Indicated for management of hypocalcemia and renal osteodystrophy in patients with chronic kidney disease, hypoparathyroidism, pseudohypoparathyroidism, and severe osteoporosis.
L-Methylfolate calcium 7.5mg Tablet
Calcium Formulations (Calcium Carbonate 500mg/1250mg, Calcium Citrate Malate 250mg/1000mg, Coral Calcium with Vitamin D3 250-2000 IU, Vitamin K2-7, Magnesium, and Zinc) is an oral bone remineralization complex on the WHO Model List of Essential Medicines. Calcium provides elemental bone mineral matrix; vitamin D3 stimulates intestinal calcium transport; vitamin K2-7 (menaquinone-7) activates osteocalcin to bind calcium into hydroxyapatite crystals while preventing ectopic arterial vascular calcification; zinc and magnesium act as essential osteoblast cofactors. Indicated for prevention and treatment of postmenopausal osteoporosis, osteopenia, pregnancy/lactation calcium demands, and bone fracture healing.